Clinical Trial Update: Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing maintenance therapy with lenalidomide and dexamethasone versus lenalidomide, dexamethasone plus ixazomib after autologous stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• NINLARO (ixazomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED